Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 Incidence

• Zhiyun Gao ,

  Contributed equally to this work with: Zhiyun Gao, Hao Yan

  Affiliations National HIV/HCV Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China, Department of Pathogenic Biology, Hebei Medical University, Shijiazhuang, China

  ⨯
• Hao Yan ,

  Contributed equally to this work with: Zhiyun Gao, Hao Yan

  Affiliations National HIV/HCV Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China

  ⨯
• Xia Feng,

  Affiliations National HIV/HCV Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China, Beijing YouAn Hospital, Capital Medical University, Beijing, China

  ⨯
• Lijin Wu,

  Affiliation Beijing KingHawk Pharmaceutical Co., Ltd., Beijing, China

  ⨯
• Maofeng Qiu,

  Affiliation National HIV/HCV Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

  ⨯
• Wenge Xing,

  Affiliation National HIV/HCV Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

  ⨯
• Guiyun Zhang,

  Affiliation National HIV/HCV Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

  ⨯
• Zhi Zhang,

  Affiliation Beijing KingHawk Pharmaceutical Co., Ltd., Beijing, China

  ⨯
• Yan Jiang

  * E-mail: jiangyan03@263.net

  Affiliation National HIV/HCV Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

  ⨯